Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Held by: CEFS YYY PCEF

Index	-	P/E	7.17	EPS (ttm)	2.04	Insider Own	-	Shs Outstand	99.47M	Perf Week	-2.21%
Market Cap	1.46B	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	99.34M	Perf Month	-4.69%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	37.63%	Short Float	0.03%	Perf Quarter	-7.58%
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.05	Perf Half Y	-12.13%
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.03M	Perf YTD	-4.88%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	17.14 -14.64%	Perf Year	-9.69%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	13.35 9.59%	Perf 3Y	2.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	1.63% 1.32%	Perf 5Y	-
Dividend TTM	3.48 (23.78%)	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	Mar 13, 2026	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	31.49	Recom	-
Dividend Gr. 3/5Y	48.12% -	Current Ratio	-	EPS Q/Q	-	SMA20	-2.83%	Beta	0.93	Target Price	-
Payout	119.87%	Debt/Eq	-	Sales Q/Q	-	SMA50	-4.82%	Rel Volume	0.95	Prev Close	14.57
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-8.48%	Avg Volume	520.55K	Price	14.63
IPO	Sep 28, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	495,127	Change	0.41%

Feb-27-26 04:31PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Nov-14-25 04:30PM	Certain BlackRock Closed-End Funds Announce Renewal of Discount Management Programs (Business Wire)
Nov-03-25 05:23PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Oct-01-25 08:19PM	Certain BlackRock Closed-End Funds Provide Updates on their Discount Management Programs (Business Wire)
05:51PM	Loading…
05:51PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Sep-02-25 05:26PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Jul-31-25 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Jul-01-25 08:00AM	BlackRock ESG Capital Allocation Term Trust's (ECAT) Certified Results of 2025 Annual Meeting Announced (Business Wire)
Jun-30-25 04:31PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Jun-23-25 08:00AM	Three Leading Proxy Advisors Recommend ECAT Shareholders Support Board Nominees and Oppose Saba's Termination Proposal Ahead of June 26 Annual Meeting (Business Wire)
Jun-18-25 04:10PM	ISS Recommends ECAT Shareholders Vote to Support Nine out of Ten Board Nominees and Against Saba's Termination Proposal (Business Wire)
Jun-17-25 09:14AM	Glass Lewis Recommends Shareholders Vote for ECAT Board Nominees and Against Saba's Proposal to Terminate BlackRock as Investment Adviser at Upcoming Annual Meeting (Business Wire)
Jun-02-25 05:27PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
May-30-25 04:31PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
07:40PM	Loading…
Apr-30-25 07:40PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Apr-25-25 05:26AM	4 CEFs To Consider For Your High-Yield Income Compounder Portfolio (Seeking Alpha)
Apr-14-25 03:01PM	8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025 (Seeking Alpha)
Apr-13-25 02:00PM	CEF Weekly Review: BlackRock Resets Its Tender Offers (Seeking Alpha)
Apr-01-25 06:57PM	Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs (Business Wire)
Mar-31-25 05:35PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Mar-28-25 04:54PM	QQQX: Attractive Discount On Top Of Latest Market Pullback (Seeking Alpha)
Mar-27-25 01:45PM	BlackRock ESG Capital Allocation Term Trust Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 10:48AM	BlackRock ESG Capital Allocation Term Trust (ECAT): Among Stocks Receiving the Most Insider Love in March (InsiderMonkey)
Mar-03-25 06:49PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Feb-28-25 04:59PM	Certain BlackRock Closed-End Funds Announce Renewal of Discount Management Programs (Business Wire)
Feb-03-25 05:16PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Jan-02-25 04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
04:30PM	Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs (Business Wire)
Dec-23-24 07:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
02:41PM	Loading…
Nov-29-24 02:41PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Nov-18-24 09:32PM	Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers (Business Wire)
09:17PM	Certain BlackRock Funds Announce Final Results of Tender Offers (Business Wire)
Oct-31-24 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Oct-01-24 04:30PM	Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs (Business Wire)
Sep-12-24 07:30PM	Distribution Dates and Amounts Announced for ECAT, BCAT, BMEZ, BSTZ and BIGZ (Business Wire)
Sep-03-24 04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Aug-30-24 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Aug-22-24 08:30PM	Certain BlackRock Funds Announce Final Results of Tender Offers (Business Wire)
Aug-21-24 08:30PM	Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers (Business Wire)
Aug-01-24 04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Jul-31-24 05:00PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Jul-01-24 05:00PM	Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs (Business Wire)
04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
08:00AM	Saba Capital Corrects BlackRocks Intentionally False and Misleading 2024 Annual Meeting Results (Business Wire)
Jun-28-24 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Jun-26-24 01:30PM	U.S. Court of Appeals for the Second Circuit Reaffirms Ruling That Certain Closed-End Funds, Including Funds Advised by BlackRock, Violated the Investment Company Act of 1940 (Business Wire)
Jun-25-24 08:10PM	U.S. District Court for the Southern District of New York Denies BlackRocks Motion to Dismiss Saba Capitals Entrenchment Bylaw Lawsuit (Business Wire)
Jun-13-24 08:53AM	ISS Recommends Shareholders Vote the GOLD Proxy Card FOR Saba Capitals Nominees at Four Major BlackRock Closed-End Funds (Business Wire)
Jun-11-24 12:20PM	ISS Endorses ALL of Saba Capitals Nominees at the BlackRock Science and Technology Term Trust and BlackRock California Municipal Income Trust (Business Wire)
Jun-03-24 04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
May-31-24 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
May-30-24 08:00AM	Saba Capital Shares Key Facts That Reinforce the Urgent Need for Change at 10 BlackRock Closed-End Funds (Business Wire)
May-20-24 07:00AM	Saba Capital Releases Presentation Detailing Plan to Deliver Enhanced Shareholder Value at 10 BlackRock Closed-End Funds (Business Wire)
06:00AM	BlackRock Announces Increased Distribution Rates for Certain Closed-End Funds (Business Wire)
May-03-24 06:05PM	Certain BlackRock Closed-End Funds Announce Adoption of Discount Management Program (Business Wire)
May-01-24 04:30PM	Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Apr-30-24 04:30PM	Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Mar-06-24 02:30PM	Saba Launches Campaign to Improve the Boards of 10 Poorly Governed and Underperforming Closed-End Funds Managed by BlackRock (Business Wire)
Jan-02-24 05:00PM	BlackRock ESG Capital Allocation Term Trust (ECAT) Announces Increase to Distribution Under Managed Distribution Plan (Business Wire)
Dec-07-23 08:00AM	U.S. District Court for the Southern District of New York Rules That Certain Closed-End Funds, Including Funds Advised by BlackRock, Violated the Investment Company Act of 1940 (Business Wire)
Oct-10-23 04:30PM	BIGZ, BMEZ, BSTZ, BCAT, and ECAT Repurchased over $137 Million of Shares in 2023 (Business Wire)
Aug-24-23 06:00PM	BlackRock Announces Release of Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, ECAT, and BMN) and Private Investment Report (Business Wire)
Jul-31-23 11:20AM	Hedge Funds Target Closed-End Funds With Arbitrage Plays (The Wall Street Journal)
Jul-03-23 09:15AM	Leading Independent Proxy Advisory Firm ISS Supports Saba Capitals Case for Change at Three BlackRock Closed-End Funds (Business Wire)
Mar-31-23 04:30PM	BlackRock Announces Name Changes for Five Closed-End Funds with Contingent Limited Terms (Business Wire)
Feb-16-23 04:30PM	BlackRock Announces Release of Fourth Quarter Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, ECAT, and BMN) (Business Wire)
Feb-01-23 04:30PM	BlackRock Capital Allocation Trust (BCAT) and BlackRock ESG Capital Allocation Trust (ECAT) Announce Increases to Distribution Rates Under Managed Distribution Plan (Business Wire)
Jan-24-23 09:15AM	BlackRock ESG Capital Allocation Trust (ECAT) and BlackRock Capital Allocation Trust (BCAT) conference call featuring Rick Rieder to be held on Wednesday, January 25th at 2:00pm ET (Business Wire)
Jan-03-23 06:26AM	Daily Vickers Top Buyers & Sellers for 01/03/2023 (Argus Research)
Nov-30-22 09:15AM	BlackRock to Host Tax-Loss Harvesting & Closed-End Fund Opportunities Conference Call on December 1, 2022 at 2:00pm ET (Business Wire)
Aug-16-22 04:30PM	BlackRock Announces Release of Second Quarter Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, and ECAT) (Business Wire)
May-10-22 04:30PM	BlackRock Closed-End Funds Call Replay Now Available (Business Wire)
May-04-22 04:30PM	BlackRock Announces Release of First Quarter Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, and ECAT) (Business Wire)
Apr-12-22 04:30PM	BlackRock Closed-End Fund ("CEF") Call on Thursday, April 14th at 10:30am ET (Business Wire)
Feb-03-22 01:38PM	Moisand Fitzgerald Tamayo, LLC Buys Dimensional International Core Equity Market ETF, Avantis ... (GuruFocus.com)
Feb-01-22 05:30PM	BlackRock Announces Release of Fourth Quarter Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, and ECAT) (Business Wire)
Nov-29-21 04:30PM	BlackRock ESG Capital Allocation Trust Announces Initial Distribution (Business Wire)
Nov-19-21 04:30PM	Certain BlackRock Limited Term Closed-End Funds Announce Share Repurchase Programs (Business Wire)

BlackRock ESG Capital Allocation Trust's (ECAT) (the 'Trust') investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust invests in a portfolio of equity and debt securities. Generally, the Trust's portfolio will include both equity and debt securities. At any given time, however, the Trust may emphasize either debt securities or equity securities. The Trust will invest at least 80% of its total assets in securities that, in the Advisor?s assessment, meet the environmental, social and governance ("ESG") criteria as described in the Trust's prospectus and shareholder reports. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saba Capital Management, L.P.	10% Owner	Mar 05 '26	Sale	14.79	126,171	1,866,069	22,744,309	Mar 09 09:45 PM
Saba Capital Management, L.P.	10% Owner	Mar 06 '26	Sale	14.58	21,200	309,096	22,723,109	Mar 09 09:45 PM
Saba Capital Management, L.P.	10% Owner	Mar 03 '26	Sale	14.92	174,550	2,604,286	22,949,058	Mar 05 09:33 AM
Saba Capital Management, L.P.	10% Owner	Mar 04 '26	Sale	15.01	78,578	1,179,456	22,870,480	Mar 05 09:33 AM
Saba Capital Management, L.P.	10% Owner	Mar 02 '26	Sale	15.15	244,943	3,710,886	23,123,608	Mar 03 10:18 AM
Saba Capital Management, L.P.	10% Owner	Feb 26 '26	Sale	15.21	126,687	1,926,909	23,448,370	Mar 02 03:06 PM
Saba Capital Management, L.P.	10% Owner	Feb 27 '26	Sale	15.16	79,819	1,210,056	23,368,551	Mar 02 03:06 PM
Saba Capital Management, L.P.	10% Owner	Feb 25 '26	Sale	15.27	59,356	906,366	23,575,057	Feb 26 03:02 PM
Saba Capital Management, L.P.	10% Owner	Feb 24 '26	Sale	15.09	34,797	525,087	23,634,413	Feb 26 03:02 PM
Saba Capital Management, L.P.	10% Owner	Feb 19 '26	Sale	15.03	61,235	920,362	23,683,123	Feb 23 12:23 PM
Saba Capital Management, L.P.	10% Owner	Feb 20 '26	Sale	15.07	13,913	209,669	23,669,210	Feb 23 12:23 PM
Saba Capital Management, L.P.	10% Owner	Feb 17 '26	Sale	15.06	113,401	1,707,819	23,790,246	Feb 19 11:40 AM
Saba Capital Management, L.P.	10% Owner	Feb 18 '26	Sale	15.11	45,888	693,368	23,744,358	Feb 19 11:40 AM
Saba Capital Management, L.P.	10% Owner	Feb 12 '26	Sale	15.47	234,005	3,620,057	23,954,247	Feb 17 03:06 PM
Saba Capital Management, L.P.	10% Owner	Feb 13 '26	Sale	15.22	50,600	770,132	23,903,647	Feb 17 03:06 PM
Saba Capital Management, L.P.	10% Owner	Feb 11 '26	Sale	15.60	156,858	2,446,985	24,188,252	Feb 12 10:04 AM
Saba Capital Management, L.P.	10% Owner	Feb 09 '26	Sale	15.55	96,973	1,507,930	24,409,211	Feb 11 01:08 PM
Saba Capital Management, L.P.	10% Owner	Feb 10 '26	Sale	15.60	64,101	999,976	24,345,110	Feb 11 01:08 PM
Saba Capital Management, L.P.	10% Owner	Feb 05 '26	Sale	15.11	131,090	1,980,770	24,542,228	Feb 09 03:09 PM
Saba Capital Management, L.P.	10% Owner	Feb 06 '26	Sale	15.29	36,044	551,113	24,506,184	Feb 09 03:09 PM
Saba Capital Management, L.P.	10% Owner	Feb 04 '26	Sale	15.28	151,192	2,310,214	24,673,318	Feb 05 11:49 AM
Saba Capital Management, L.P.	10% Owner	Feb 03 '26	Sale	15.38	143,707	2,210,214	24,824,510	Feb 05 11:49 AM
Saba Capital Management, L.P.	10% Owner	Feb 02 '26	Sale	15.55	178,239	2,771,616	24,968,217	Feb 03 02:56 PM
Saba Capital Management, L.P.	10% Owner	Jan 29 '26	Sale	15.44	166,027	2,563,457	25,304,283	Feb 02 10:59 AM
Saba Capital Management, L.P.	10% Owner	Jan 30 '26	Sale	15.46	157,827	2,440,005	25,146,456	Feb 02 10:59 AM
Saba Capital Management, L.P.	10% Owner	Jan 28 '26	Sale	15.53	105,896	1,644,565	25,470,310	Jan 29 10:10 AM
Saba Capital Management, L.P.	10% Owner	Jan 27 '26	Sale	15.54	83,984	1,305,111	25,576,206	Jan 29 10:10 AM
Saba Capital Management, L.P.	10% Owner	Jan 26 '26	Sale	15.54	44,054	684,599	25,660,190	Jan 27 01:31 PM
Saba Capital Management, L.P.	10% Owner	Jan 23 '26	Sale	15.50	58,213	902,302	25,704,244	Jan 26 01:25 PM
Saba Capital Management, L.P.	10% Owner	Jan 22 '26	Sale	15.50	35,831	555,380	25,762,457	Jan 26 01:25 PM
Saba Capital Management, L.P.	10% Owner	Jan 21 '26	Sale	15.38	169,776	2,611,155	25,798,288	Jan 22 01:02 PM
Saba Capital Management, L.P.	10% Owner	Jan 20 '26	Sale	15.39	102,837	1,582,661	25,968,064	Jan 22 01:02 PM
Saba Capital Management, L.P.	10% Owner	Jan 15 '26	Sale	15.97	80,452	1,284,818	26,146,336	Jan 20 05:22 PM
Saba Capital Management, L.P.	10% Owner	Jan 16 '26	Sale	15.94	75,435	1,202,434	26,070,901	Jan 20 05:22 PM
Saba Capital Management, L.P.	10% Owner	Jan 14 '26	Sale	15.89	75,713	1,203,080	26,226,788	Jan 15 10:14 AM
Saba Capital Management, L.P.	10% Owner	Jan 13 '26	Sale	15.92	11,153	177,556	26,302,501	Jan 15 10:14 AM
Saba Capital Management, L.P.	10% Owner	Jan 06 '26	Sale	15.75	9,943	156,602	26,313,654	Jan 08 10:32 AM
Saba Capital Management, L.P.	10% Owner	Jan 02 '26	Sale	15.45	12,660	195,597	26,323,597	Jan 05 10:53 AM
Saba Capital Management, L.P.	10% Owner	Dec 24 '25	Sale	15.57	1,100	17,127	26,336,257	Dec 30 07:10 PM
Saba Capital Management, L.P.	10% Owner	Dec 01 '25	Sale	16.03	54,394	871,936	26,337,357	Dec 02 10:11 AM
Saba Capital Management, L.P.	10% Owner	Nov 28 '25	Sale	16.02	9,389	150,412	26,726,410	Dec 02 10:11 AM
Saba Capital Management, L.P.	10% Owner	Nov 26 '25	Sale	16.00	56,976	911,616	26,735,799	Dec 01 05:48 PM
Saba Capital Management, L.P.	10% Owner	Nov 25 '25	Sale	15.80	49,669	784,770	26,792,775	Nov 26 01:31 PM
Saba Capital Management, L.P.	10% Owner	Nov 24 '25	Sale	15.65	10,891	170,444	26,842,444	Nov 25 09:52 AM
Saba Capital Management, L.P.	10% Owner	Nov 19 '25	Sale	15.64	9,750	152,490	26,853,335	Nov 20 04:38 PM
Saba Capital Management, L.P.	10% Owner	Nov 17 '25	Sale	15.85	44,604	706,973	26,863,085	Nov 18 07:02 PM
Saba Capital Management, L.P.	10% Owner	Nov 14 '25	Sale	16.30	90,456	1,474,433	26,907,689	Nov 17 09:59 AM
Saba Capital Management, L.P.	10% Owner	Nov 13 '25	Sale	16.45	62,082	1,021,249	26,998,145	Nov 17 09:59 AM
Saba Capital Management, L.P.	10% Owner	Nov 11 '25	Sale	16.39	39,740	651,339	27,060,227	Nov 12 10:22 AM
Saba Capital Management, L.P.	10% Owner	Nov 10 '25	Sale	16.28	17,653	287,391	27,099,967	Nov 12 10:22 AM
Saba Capital Management, L.P.	10% Owner	Nov 06 '25	Sale	16.10	57,053	918,553	27,117,620	Nov 10 10:34 AM
Saba Capital Management, L.P.	10% Owner	Nov 05 '25	Sale	16.30	49,369	804,715	27,174,673	Nov 06 12:03 PM
Saba Capital Management, L.P.	10% Owner	Nov 04 '25	Sale	16.30	3,600	58,680	27,224,042	Nov 06 12:03 PM
Saba Capital Management, L.P.	10% Owner	Nov 03 '25	Sale	16.40	70,661	1,158,840	27,227,642	Nov 04 04:12 PM
Saba Capital Management, L.P.	10% Owner	Oct 30 '25	Sale	16.46	78,022	1,284,242	27,322,348	Nov 03 11:50 AM
Saba Capital Management, L.P.	10% Owner	Oct 31 '25	Sale	16.42	24,045	394,819	27,298,303	Nov 03 11:50 AM
Saba Capital Management, L.P.	10% Owner	Oct 29 '25	Sale	16.55	75,953	1,257,022	27,400,370	Oct 30 03:55 PM
Saba Capital Management, L.P.	10% Owner	Oct 28 '25	Sale	16.64	1,200	19,968	27,476,323	Oct 30 03:55 PM
Saba Capital Management, L.P.	10% Owner	Oct 27 '25	Sale	16.53	25,802	426,507	27,477,523	Oct 28 12:40 PM
Saba Capital Management, L.P.	10% Owner	Oct 23 '25	Sale	16.32	26,032	424,842	27,503,325	Oct 27 06:52 PM
Saba Capital Management, L.P.	10% Owner	Oct 22 '25	Sale	16.25	28,112	456,820	27,529,357	Oct 23 12:15 PM
Saba Capital Management, L.P.	10% Owner	Oct 14 '25	Sale	16.53	50,936	841,972	27,567,322	Oct 16 10:13 AM
Saba Capital Management, L.P.	10% Owner	Oct 15 '25	Sale	16.26	6,233	101,349	27,561,089	Oct 16 10:13 AM
Saba Capital Management, L.P.	10% Owner	Oct 10 '25	Sale	16.59	26,858	445,574	27,637,666	Oct 14 11:02 AM
Saba Capital Management, L.P.	10% Owner	Oct 13 '25	Sale	16.58	19,408	321,785	27,618,258	Oct 14 11:02 AM
Saba Capital Management, L.P.	10% Owner	Oct 09 '25	Sale	16.62	13,647	226,813	27,664,524	Oct 14 11:02 AM
Saba Capital Management, L.P.	10% Owner	Oct 08 '25	Sale	16.64	32,386	538,903	27,678,171	Oct 09 10:24 AM
Saba Capital Management, L.P.	10% Owner	Oct 07 '25	Sale	16.57	30,072	498,293	27,710,557	Oct 08 10:27 AM
Saba Capital Management, L.P.	10% Owner	Oct 06 '25	Sale	16.65	5,792	96,437	27,743,504	Oct 08 10:27 AM
Saba Capital Management, L.P.	10% Owner	Oct 03 '25	Sale	16.65	30,649	510,306	27,746,421	Oct 06 02:41 PM
Saba Capital Management, L.P.	10% Owner	Oct 02 '25	Sale	16.56	5,524	91,477	27,777,070	Oct 06 02:41 PM
Saba Capital Management, L.P.	10% Owner	Oct 01 '25	Sale	16.55	18,130	300,052	27,782,594	Oct 02 10:23 AM
Saba Capital Management, L.P.	10% Owner	Sep 30 '25	Sale	16.44	1,063	17,476	27,800,724	Oct 02 10:23 AM
Saba Capital Management, L.P.	10% Owner	Sep 25 '25	Sale	16.24	1,113	18,075	27,801,787	Sep 29 12:10 PM
Saba Capital Management, L.P.	10% Owner	Sep 24 '25	Sale	16.39	28,886	473,442	27,802,900	Sep 25 03:19 PM
Saba Capital Management, L.P.	10% Owner	Sep 23 '25	Sale	16.45	17,785	292,563	27,831,786	Sep 25 03:19 PM
Saba Capital Management, L.P.	10% Owner	Sep 16 '25	Sale	16.51	5,776	95,362	27,849,571	Sep 17 11:37 AM
Saba Capital Management, L.P.	10% Owner	Sep 12 '25	Sale	16.79	19,682	330,461	27,855,347	Sep 15 05:26 PM
Saba Capital Management, L.P.	10% Owner	Sep 11 '25	Sale	16.76	4,006	67,141	27,875,029	Sep 15 05:26 PM
Saba Capital Management, L.P.	10% Owner	Sep 10 '25	Sale	16.70	109,895	1,835,246	27,879,035	Sep 11 09:33 AM
Saba Capital Management, L.P.	10% Owner	Sep 09 '25	Sale	16.69	76,416	1,275,383	27,988,930	Sep 11 09:33 AM
Saba Capital Management, L.P.	10% Owner	Sep 08 '25	Sale	16.66	79,152	1,318,672	28,065,346	Sep 09 11:56 AM
Saba Capital Management, L.P.	10% Owner	Sep 04 '25	Sale	16.55	91,395	1,512,587	28,211,871	Sep 08 12:28 PM
Saba Capital Management, L.P.	10% Owner	Sep 05 '25	Sale	16.56	67,373	1,115,697	28,144,498	Sep 08 12:28 PM
Saba Capital Management, L.P.	10% Owner	Sep 02 '25	Sale	16.38	130,848	2,143,290	28,393,148	Sep 04 10:25 AM
Saba Capital Management, L.P.	10% Owner	Sep 03 '25	Sale	16.50	89,882	1,483,053	28,303,266	Sep 04 10:25 AM
Saba Capital Management, L.P.	10% Owner	Aug 29 '25	Sale	16.51	76,648	1,265,458	28,523,996	Sep 02 04:09 PM
Saba Capital Management, L.P.	10% Owner	Aug 28 '25	Sale	16.63	4,397	73,122	28,600,644	Sep 02 04:09 PM
BlackRock, Inc.		Mar 24 '25	Buy	16.34	46,745	763,813	1,223,545	Mar 24 06:13 PM
BlackRock, Inc.		Mar 21 '25	Buy	16.20	101,600	1,645,920	1,176,800	Mar 21 05:36 PM
BlackRock, Inc.		Mar 20 '25	Buy	16.31	101,600	1,657,096	1,075,200	Mar 20 06:09 PM
BlackRock, Inc.		Mar 19 '25	Buy	16.21	101,600	1,646,936	973,600	Mar 19 07:46 PM
BlackRock, Inc.		Mar 18 '25	Buy	16.12	101,600	1,637,792	872,000	Mar 18 06:53 PM
BlackRock, Inc.		Mar 17 '25	Buy	16.18	101,600	1,643,888	770,400	Mar 17 06:58 PM
BlackRock, Inc.		Mar 14 '25	Buy	16.16	86,000	1,389,760	668,800	Mar 14 07:22 PM
BlackRock, Inc.		Mar 13 '25	Buy	16.41	86,000	1,411,260	582,800	Mar 13 06:27 PM
BlackRock, Inc.		Mar 12 '25	Buy	16.43	86,000	1,412,980	496,800	Mar 12 06:27 PM

Open in Screener

PGR

Progressive Corp

Mar 10 • 04:00PM ET

206.96

+0.16 0.08 %

Financial • Insurance - Property & Casualty • USA • NYSE

Peers: ALL TRV CINF CB HIG MKL WRB SIGI ACGL

| Held by: VTI VOO IVV SPY VTV XLF VYM IWD USMV SPHQ

Index	S&P 500	P/E	10.75	EPS (ttm)	19.25	Insider Own	0.29%	Shs Outstand	586.00M	Perf Week	-3.00%
Market Cap	121.26B	Forward P/E	12.82	EPS next Y	16.15	Insider Trans	-1.76%	Shs Float	584.22M	Perf Month	2.31%
Enterprise Value	-	PEG	-	EPS next Q	4.68	Inst Own	88.05%	Short Float	1.24%	Perf Quarter	-7.15%
Income	11.31B	P/S	1.38	EPS this Y	-10.54%	Inst Trans	0.37%	Short Ratio	2.09	Perf Half Y	-15.85%
Sales	87.64B	P/B	4.00	EPS next Y	-0.07%	ROA	10.19%	Short Interest	7.24M	Perf YTD	-9.12%
Book/sh	51.75	P/C	-	EPS next 5Y	-4.21%	ROE	40.45%	52W High	292.99 -29.36%	Perf Year	-25.74%
Cash/sh	-	P/FCF	7.05	EPS past 3/5Y	153.30% 14.75%	ROIC	30.22%	52W Low	197.92 4.57%	Perf 3Y	50.58%
Dividend Est.	8.40 (4.06%)	EV/EBITDA	-	Sales past 3/5Y	20.90% 15.50%	Gross Margin	-	Volatility	1.95% 2.25%	Perf 5Y	133.05%
Dividend TTM	13.90 (6.72%)	EV/Sales	-	EPS Y/Y TTM	33.49%	Oper. Margin	16.55%	ATR (14)	4.79	Perf 10Y	606.69%
Dividend Ex-Date	Apr 02, 2026	Quick Ratio	-	Sales Y/Y TTM	16.32%	Profit Margin	12.90%	RSI (14)	47.04	Recom	2.43
Dividend Gr. 3/5Y	226.33% 23.19%	Current Ratio	0.76	EPS Q/Q	24.80%	SMA20	-0.28%	Beta	0.31	Target Price	240.25
Payout	72.29%	Debt/Eq	0.23	Sales Q/Q	12.19%	SMA50	-1.05%	Rel Volume	0.85	Prev Close	206.80
Employees	70053	LT Debt/Eq	0.23	Earnings	Jan 28 BMO	SMA200	-11.63%	Avg Volume	3.46M	Price	206.96
IPO	Mar 17, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.25% -3.90%	Trades		Volume	2,996,870	Change	0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-26	Upgrade	Barclays	Equal Weight → Overweight	$265
Dec-18-25	Downgrade	William Blair	Outperform → Mkt Perform
Dec-16-25	Initiated	Mizuho	Neutral	$242
Nov-17-25	Upgrade	HSBC Securities	Hold → Buy
Nov-14-25	Downgrade	Jefferies	Buy → Hold
Oct-20-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$214
Sep-18-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$265
Sep-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$250
Sep-16-25	Initiated	Wolfe Research	Peer Perform
Aug-13-25	Initiated	Citigroup	Buy	$312
Aug-13-25	Initiated	Cantor Fitzgerald	Neutral	$240
Jul-17-25	Downgrade	Evercore ISI	Outperform → In-line	$275
Jul-07-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$290
Apr-28-25	Upgrade	BofA Securities	Neutral → Buy	$312
Apr-17-25	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$288
Apr-04-25	Downgrade	BofA Securities	Buy → Neutral	$287
Dec-26-24	Upgrade	Raymond James	Mkt Perform → Outperform	$305
Dec-10-24	Downgrade	HSBC Securities	Buy → Hold	$267
Sep-05-24	Initiated	Barclays	Equal Weight	$367
Aug-15-24	Upgrade	Goldman	Neutral → Buy	$230 → $262

Show Previous Ratings

Mar-09-26 05:45PM	Progressive (PGR) Stock Dips While Market Gains: Key Facts (Zacks)
10:47AM	Progressive Announces Quarterly Common Share Dividend (GlobeNewswire)
Mar-06-26 02:41PM	Analyst Report: The Progressive Corporation (Morningstar Research)
09:00AM	Investors Heavily Search The Progressive Corporation (PGR): Here is What You Need to Know (Zacks)
06:54AM	Allstate Corporation Stock: Is ALL Outperforming the Financial Sector? (Barchart)
03:44AM	Loading…
03:44AM	Progressive Corporation (PGR) Among the Best Value Stocks to Buy for Long Term (Insider Monkey)
Mar-04-26 07:38AM	After SaaSocalypse And Cybersecurity Sell Off, This $15 Billion Sector Could Be The Next Target (Benzinga)
Mar-03-26 04:02PM	Progressive Corp (PGR) Q4 2025 Earnings Call Highlights: Record Growth and Strategic ... (GuruFocus.com)
04:02PM	Progressive Q4 Earnings Call Highlights (MarketBeat)
09:55AM	Chubb's Dividend Hikes Backed by Earnings Power & Solid Cash Flow? (Zacks)
08:30AM	The Progressive Corporation Q4 2025 Earnings Call Summary (Moby)
Mar-02-26 07:42AM	Progressive Stock: Is PGR Underperforming the Financial Sector? (Barchart)
Feb-28-26 09:36PM	UBS Cuts Progressive (PGR) Valuation While Maintaining Neutral View (Insider Monkey)
07:32AM	UBS Cuts Target on Progressive (PGR), Maintains Neutral Rating (Insider Monkey)
Feb-27-26 11:30AM	Progressive (PGR) Up 1.7% Since Last Earnings Report: Can It Continue? (Zacks)
10:41AM	Loading…
Feb-26-26 10:41AM	BRK.B Trading at a Discount to 52-Week High: What Should Investors Do? (Zacks)
Feb-25-26 07:54AM	Strength Seen in Heritage Insurance (HRTG): Can Its 17.9% Jump Turn into More Strength? (Zacks)
12:43AM	BofA Lowers its Price Target on The Progressive Corporation (PGR) to $315 from $329 and Maintains a Buy Rating (Insider Monkey)
Feb-24-26 12:51PM	Progressive Announces Investor Relations Event (GlobeNewswire)
Feb-20-26 05:45PM	Progressive (PGR) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
03:13PM	The Progressive Corporation (PGR) Reports Jan 2025 Results (Insider Monkey)
Feb-19-26 09:00AM	The Progressive Corporation (PGR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:23AM	Progressive's January Earnings Increase Y/Y on Higher Premiums (Zacks)
Feb-18-26 12:03PM	What Should You Do With Berkshire Stock Ahead of Q4 Earnings? (Zacks)
08:16AM	Progressive Reports January 2026 Results (GlobeNewswire)
02:28AM	Daniel Loeb's Third Point Loads Up On Chipotle, Constellation, Alibaba While Slashing TSM, Amazon in Q4 Shake-Up (Benzinga)
Feb-12-26 11:24AM	FAF Q4 Earnings Top, Revenues Rise Y/Y on Strong Title Segment (Zacks)
11:01AM	Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y (Zacks)
04:42AM	The Progressive Corporation (PGR) In a Phase of Robust Growth Amid Advertising Efficiency (Insider Monkey)
Feb-11-26 03:02PM	Brandes Investment Partners, LP's Strategic Moves: Progressive Corp Leads with 1. ... (GuruFocus.com)
01:26PM	Loading…
01:26PM	AIG Q4 Earnings Beat Estimates, Up Y/Y on Solid Underwriting (Zacks)
Feb-10-26 08:46AM	Auto Insurance Premiums Wont Stop Rising, Even for Careful Drivers (24/7 Wall St.)
07:53AM	Progressive Corporation Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Feb-09-26 01:03PM	Bears Are Missing The Big Picture On Progressive: Analyst (Benzinga)
10:50AM	TRV Stock Near 52-Week High: A Signal for Investors to Hold Tight? (Zacks)
Feb-07-26 11:32AM	The Progressive Corporation (PGR): A Bull Case Theory (Insider Monkey)
Feb-06-26 02:14PM	Insurance Stocks Gain Ground in Turbulent Markets. Boring Might Be the Way to Go. (Barrons.com)
Feb-05-26 09:00AM	The Progressive Corporation (PGR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Feb-03-26 11:27AM	MGIC Q4 Earnings Beat Estimates, Revenues Miss, Insurance in Force Up Y/Y (Zacks)
Jan-30-26 09:11AM	Selective Insurance 4Q Earnings Beat Estimates on Solid Underwriting (Zacks)
Jan-29-26 08:34AM	AXIS Capital Reports Q4 Earnings Growth Despite Higher Expenses (Zacks)
08:21AM	Stock Market News for Jan 29, 2026 (Zacks)
04:39AM	Progressive CFO Sauerland to step down in July 2026 (Life Insurance International)
02:07AM	Is Progressive Corporation (PGR) One of the Best Inexpensive Stocks to Buy Now? (Insider Monkey)
Jan-28-26 01:01PM	Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? (Benzinga)
11:23AM	Earnings Drive Early Market Moves (Zacks)
10:40AM	Big Earnings Day Sandwich Fed's Interest Rate Decision (Zacks)
10:30AM	Progressive (PGR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
10:29AM	Progressive's Q4 Earnings & Revenues Beat Estimates on Higher Premiums (Zacks)
10:02AM	Analyst Report: The Progressive Corporation (Morningstar Research)
09:20AM	Progressive (PGR) Q4 Earnings and Revenues Top Estimates (Zacks)
08:26AM	Progressive: Q4 Earnings Snapshot (Associated Press Finance)
08:14AM	Progressive Announces Plans For CFO Transition (GlobeNewswire)
08:03AM	Progressive Reports December 2025 Results (GlobeNewswire)
Jan-27-26 11:00AM	Greg Abel Signals Shift as Berkshire Weighs Kraft Heinz Exit? (Zacks)
Jan-26-26 10:11PM	Progressive (PGR) Q4 Earnings Report Preview: What To Look For (StockStory)
09:52AM	Berkshire Hathaway Stock Trades at a Premium to Industry: How to Play (Zacks)
09:41AM	Progressive Set to Report Q4 Earnings: What's in Store? (Zacks)
08:20AM	Tesla, Microsoft, Meta, SanDisk And More: Stocks With Earnings This Week (Benzinga)
Jan-25-26 07:52AM	Big Tech earnings, Fed meeting feature as markets end January with busiest week of Q1: What to watch (Yahoo Finance)
Jan-23-26 09:15AM	Progressive (PGR) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Jan-22-26 05:50PM	Progressive (PGR) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
02:32PM	Lemonade's Tesla Deal Could Rewrite How Auto Insurance Is Priced (MarketBeat)
10:24AM	RLI's Q4 Earnings Beat Estimates on Strong Net Investment Income (Zacks)
09:00AM	The Progressive Corporation (PGR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-21-26 11:26AM	Travelers Q4 Earnings Beat on Strong Net Investment Income (Zacks)
10:00AM	Progressive (PGR) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-20-26 10:00AM	Progressive Insurance Introduces Pet Insurance for Cats and Dogs (PR Newswire)
Jan-16-26 07:07PM	Should You Buy This Stock After Its Recent Pullback? (Motley Fool)
09:40AM	Here's Why Progressive (PGR) is a Strong Value Stock (Zacks)
Jan-15-26 11:53PM	Analyst Report: The Progressive Corporation (Morningstar Research)
Jan-14-26 09:45AM	Why Progressive (PGR) is a Top Growth Stock for the Long-Term (Zacks)
Jan-12-26 11:11AM	Analyst Report: The Progressive Corporation (Morningstar Research)
04:29AM	Evercore ISI, BofA, and JPMorgan Reduce PT on The Progressive Corporation (PGR) Amid Slowing Industry Fundamentals (Insider Monkey)
Jan-11-26 01:00PM	Down 21% From All-Time Highs, Is Progressive Stock a Buy? (Motley Fool)
Jan-08-26 11:39PM	1 Insurance Stock to Own for Decades and 2 We Brush Off (StockStory)
05:50PM	Progressive (PGR) Laps the Stock Market: Here's Why (Zacks)
10:48AM	3 Top Dividend Stocks to Buy in January (Motley Fool)
09:00AM	The Progressive Corporation (PGR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:54AM	Progressive Corporation (PGR) Traded Down Despite Reporting Strong Earnings (Insider Monkey)
04:35AM	3 Dirt Cheap Stocks to Buy With $1,000 Right Now (Motley Fool)
Jan-07-26 06:18AM	Progressive Corporation's Quarterly Earnings Preview: What You Need to Know (Barchart)
Jan-02-26 05:50PM	Progressive (PGR) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks) -6.85%
04:49PM	What is an insurance 'float' & what Fed rates mean for insurers (Yahoo Finance Video)
04:37PM	Stocks Settle Mixed on Strength in Chip Makers and Weakness in Megacap Tech (Barchart)
11:29AM	Stocks Give Up Early Gains as Megacap Tech Shares Fall (Barchart)
Dec-31-25 11:41AM	Why is The Progressive Corporation (PGR) One of the Best Affordable Stocks With Good Earnings Growth for 2026? (Insider Monkey)
Dec-30-25 09:50AM	Here's Why Progressive (PGR) is a Strong Momentum Stock (Zacks)
Dec-24-25 11:02AM	BRK.B Stock Moves Above 50- & 200-Day SMA: Buy, Sell or Stay Invested? (Zacks)
Dec-23-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Dec-22-25 09:45AM	Progressive (PGR) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Dec-20-25 08:50AM	5 Blue Chip Stocks to Buy With $10,000 and Hold Forever (Motley Fool)
Dec-19-25 07:20PM	Progressive: A Strong Contender in the Insurance Market (Motley Fool)
Dec-18-25 05:45PM	Progressive (PGR) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
09:50AM	Micron upgraded, PayPal downgraded: Wall Street's top analyst calls (The Fly)
09:00AM	Investors Heavily Search The Progressive Corporation (PGR): Here is What You Need to Know (Zacks)
Dec-17-25 04:38PM	Stocks Settle Sharply Lower as Tech Stocks Routed (Barchart)
11:24AM	Stocks Retreat as AI Infrastructure Companies and Chip Makers Fall (Barchart)
09:56AM	Stocks Mixed with Energy Producers Higher and Homebuilders Lower (Barchart)
08:19AM	Progressive Reports November 2025 Results (GlobeNewswire)

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Joyce Carl G	Chief Accounting Officer	Mar 05 '26	Sale	212.00	141	29,892	828	Mar 09 01:08 PM
Bailo Karen	Commercial Lines President	Mar 05 '26	Sale	212.00	3,517	745,604	32,348	Mar 09 01:04 PM
Joyce Carl G	Officer	Mar 05 '26	Proposed Sale	212.00	141	29,892		Mar 05 11:04 AM
Bailo Karen	Officer	Mar 05 '26	Proposed Sale	212.00	3,517	745,604		Mar 05 10:48 AM
Pumarejo Maribel	Chief Marketing Oficer	Feb 24 '26	Sale	203.25	739	150,138	0	Feb 25 02:44 PM
Bauer Jonathan S.	Chief Investment Officer	Feb 23 '26	Sale	203.05	2,266	460,111	26,250	Feb 24 01:51 PM
Pumarejo Maribel	Officer	Feb 24 '26	Proposed Sale	203.16	739	150,138		Feb 24 11:44 AM
Bauer Jonathan S.	Officer	Feb 23 '26	Proposed Sale	203.05	2,266	460,111		Feb 23 09:59 AM
Quigg Andrew J	Chief Strategy Officer	Jan 21 '26	Sale	204.35	1,649	336,973	39,626	Jan 22 01:05 PM
Bauer Jonathan S.	Chief Investment Officer	Jan 21 '26	Sale	204.35	3,105	634,507	26,249	Jan 22 01:00 PM
Stringer David M	Vice Pres, Secretary and CLO	Jan 20 '26	Option Exercise	0.00	1,436	0	5,208	Jan 22 12:57 PM
Sauerland John P	VP and Chief Financial Officer	Jan 20 '26	Option Exercise	0.00	6,776	0	229,801	Jan 22 12:54 PM
Quigg Andrew J	Chief Strategy Officer	Jan 20 '26	Option Exercise	0.00	4,757	0	42,734	Jan 22 12:50 PM
Pumarejo Maribel	Chief Marketing Oficer	Jan 20 '26	Option Exercise	0.00	1,112	0	1,112	Jan 22 12:47 PM
Niederst Lori A	CRM President	Jan 20 '26	Option Exercise	0.00	5,112	0	44,152	Jan 22 12:44 PM
Murphy John Jo	Claims President	Jan 20 '26	Option Exercise	0.00	5,423	0	48,929	Jan 22 12:40 PM
Joyce Carl G	Chief Accounting Officer	Jan 20 '26	Option Exercise	0.00	486	0	1,141	Jan 22 12:36 PM
Griffith Susan Patricia	President and CEO	Jan 20 '26	Option Exercise	0.00	23,909	0	495,195	Jan 22 12:33 PM
Clawson William L. II	Chief Human Resources Officer	Jan 20 '26	Option Exercise	0.00	3,060	0	16,844	Jan 22 12:28 PM
Callahan Patrick K	Personal Lines President	Jan 20 '26	Option Exercise	0.00	6,270	0	21,462	Jan 22 12:25 PM
Broz Steven	Chief Information Officer	Jan 20 '26	Option Exercise	0.00	5,009	0	31,363	Jan 22 12:22 PM
Bauer Jonathan S.	Chief Investment Officer	Jan 20 '26	Option Exercise	0.00	4,602	0	30,850	Jan 22 11:26 AM
Bailo Karen	Commercial Lines President	Jan 20 '26	Option Exercise	0.00	5,063	0	37,409	Jan 22 11:22 AM
Bauer Jonathan S.	Officer	Jan 21 '26	Proposed Sale	204.35	3,105	634,507		Jan 21 10:56 AM
Quigg Andrew J	Officer	Jan 21 '26	Proposed Sale	204.35	1,649	336,973		Jan 21 10:30 AM
Broz Steven	Chief Information Officer	Dec 19 '25	Sale	224.80	1,344	302,131	26,354	Dec 22 11:38 AM
Broz Steven	Officer	Dec 19 '25	Proposed Sale	224.80	1,344	302,131		Dec 19 11:03 AM
Sauerland John P	VP and Chief Financial Officer	Nov 28 '25	Sale	228.48	5,000	1,142,400	223,024	Dec 01 05:09 PM
Sauerland John P	Officer	Nov 28 '25	Proposed Sale	228.48	5,000	1,142,400		Nov 28 10:21 AM
Broz Steven	Chief Information Officer	Nov 21 '25	Sale	228.29	1,345	307,050	27,698	Nov 24 09:07 AM
Broz Steven	Officer	Nov 21 '25	Proposed Sale	228.29	1,345	307,050		Nov 21 11:00 AM
Broz Steven	Chief Information Officer	Nov 11 '25	Sale	220.00	1,345	295,900	29,043	Nov 12 06:32 PM
Broz Steven	Officer	Nov 11 '25	Proposed Sale	220.00	1,345	295,900		Nov 12 07:11 AM
Murphy John Jo	Claims President	Sep 19 '25	Sale	242.10	2,218	536,978	43,506	Sep 22 12:01 PM
Callahan Patrick K	Personal Lines President	Sep 19 '25	Sale	242.22	6,420	1,555,041	15,192	Sep 22 11:55 AM
Broz Steven	Chief Information Officer	Sep 19 '25	Sale	242.10	1,345	325,624	30,388	Sep 22 11:35 AM
Callahan Patrick K	Officer	Sep 19 '25	Proposed Sale	242.22	6,420	1,555,041		Sep 19 04:20 PM
Murphy John Jo	Officer	Sep 19 '25	Proposed Sale	242.10	2,218	536,978		Sep 19 10:27 AM
Broz Steven	Officer	Sep 19 '25	Proposed Sale	242.10	1,345	325,624		Sep 19 09:53 AM
Griffith Susan Patricia	President and CEO	Sep 02 '25	Sale	246.06	30,659	7,543,892	476,286	Sep 03 01:29 PM
Griffith Susan Patricia	Officer	Sep 02 '25	Proposed Sale	247.91	30,659	7,600,673		Sep 02 03:28 PM
Murphy John Jo	Claims President	Aug 22 '25	Sale	250.78	2,218	556,230	45,724	Aug 25 11:55 AM
Callahan Patrick K	Personal Lines President	Aug 22 '25	Sale	249.96	6,232	1,557,749	21,612	Aug 25 11:51 AM
Broz Steven	Chief Information Officer	Aug 22 '25	Sale	250.78	1,345	337,299	31,733	Aug 25 11:45 AM
Callahan Patrick K	Officer	Aug 22 '25	Proposed Sale	250.78	6,232	1,562,861		Aug 22 12:31 PM
Murphy John Jo	Officer	Aug 22 '25	Proposed Sale	250.78	2,218	556,230		Aug 22 10:06 AM
Broz Steven	Officer	Aug 22 '25	Proposed Sale	250.78	1,345	337,299		Aug 22 10:05 AM
Niederst Lori A	CRM President	Aug 14 '25	Sale	250.18	8,063	2,017,201	39,040	Aug 15 11:41 AM
Kent Remi	Former Officer	Aug 14 '25	Proposed Sale	250.18	5,329	1,333,209		Aug 14 05:51 PM
Niederst Lori A	Officer	Aug 14 '25	Proposed Sale	250.18	8,063	2,017,201		Aug 14 05:42 PM
Sauerland John P	VP and Chief Financial Officer	Jul 28 '25	Sale	249.24	16,664	4,153,335	228,024	Jul 30 01:58 PM
Quigg Andrew J	Chief Strategy Officer	Jul 28 '25	Sale	249.24	3,191	795,325	37,977	Jul 30 01:53 PM
Murphy John Jo	Claims President	Jul 28 '25	Sale	249.24	2,218	552,814	47,942	Jul 30 01:50 PM
Griffith Susan Patricia	President and CEO	Jul 28 '25	Sale	242.12	30,660	7,423,298	506,945	Jul 30 01:46 PM
Callahan Patrick K	Personal Lines President	Jul 28 '25	Sale	242.16	6,232	1,509,139	27,844	Jul 30 01:41 PM
Bauer Jonathan S.	Chief Investment Officer	Jul 28 '25	Sale	249.24	2,391	595,933	26,698	Jul 30 01:37 PM
Bailo Karen	Commercial Lines President	Jul 28 '25	Sale	249.24	8,922	2,223,719	32,346	Jul 30 01:34 PM
Callahan Patrick K	Officer	Jul 28 '25	Proposed Sale	249.24	6,232	1,553,264		Jul 28 12:18 PM
Griffith Susan Patricia	Officer	Jul 28 '25	Proposed Sale	249.24	30,660	7,641,698		Jul 28 11:11 AM
Murphy John Jo	Officer	Jul 28 '25	Proposed Sale	249.24	2,218	552,814		Jul 28 10:43 AM
Bauer Jonathan S.	Officer	Jul 28 '25	Proposed Sale	249.24	2,391	595,933		Jul 28 10:34 AM
Quigg Andrew J	Officer	Jul 28 '25	Proposed Sale	249.24	3,191	795,325		Jul 28 10:29 AM
Bailo Karen	Officer	Jul 28 '25	Proposed Sale	249.24	8,922	2,223,719		Jul 28 10:16 AM
Sauerland John P	Officer	Jul 28 '25	Proposed Sale	249.24	16,664	4,153,335		Jul 28 10:05 AM
Broz Steven	Chief Information Officer	Jul 18 '25	Sale	247.54	1,267	313,633	26,354	Jul 21 02:08 PM
Broz Steven	Officer	Jul 18 '25	Proposed Sale	247.54	1,267	313,633		Jul 18 10:01 AM
Snyder Barbara R	Director	Jul 01 '25	Option Exercise	0.00	774	0	10,753	Jul 02 11:28 AM
Sauerland John P	VP and Chief Financial Officer	Jun 30 '25	Sale	263.79	10,000	2,637,900	228,024	Jul 02 11:09 AM
Sauerland John P	Officer	Jun 30 '25	Proposed Sale	263.79	10,000	2,637,900		Jun 30 10:12 AM
Murphy John Jo	Claims President	Jun 20 '25	Sale	260.38	4,000	1,041,520	41,289	Jun 23 11:32 AM
Broz Steven	Chief Information Officer	Jun 20 '25	Sale	260.38	1,267	329,901	27,621	Jun 23 11:21 AM
Burgdoerfer Stuart B	Director	Jun 20 '25	Sale	260.43	3,681	958,643	12,217	Jun 23 11:10 AM
Burgdoerfer Stuart B	Director	Jun 20 '25	Proposed Sale	260.43	3,681	958,643		Jun 20 11:47 AM
Broz Steven	Officer	Jun 20 '25	Proposed Sale	260.38	1,267	329,901		Jun 20 09:44 AM
Murphy John Jo	Officer	Jun 20 '25	Proposed Sale	260.38	4,000	1,041,520		Jun 20 09:40 AM
Sauerland John P	VP and Chief Financial Officer	May 28 '25	Sale	275.37	10,000	2,753,700	238,024	May 29 10:49 AM
Broz Steven	Chief Information Officer	May 23 '25	Sale	277.81	1,267	351,985	28,888	May 28 11:04 AM
Sauerland John P	Officer	May 28 '25	Proposed Sale	275.37	10,000	2,753,700		May 28 10:07 AM
Van Dyke Kahina	Director	May 22 '25	Sale	277.67	2,490	691,398	12,429	May 23 09:57 AM
Broz Steven	Officer	May 23 '25	Proposed Sale	277.81	1,267	351,985		May 23 09:44 AM
Van Dyke Kahina	Director	May 22 '25	Proposed Sale	277.67	2,490	691,398		May 22 04:13 PM
Sauerland John P	VP and Chief Financial Officer	Apr 28 '25	Sale	268.59	10,000	2,685,900	248,024	Apr 29 10:15 AM
Sauerland John P	Officer	Apr 28 '25	Proposed Sale	268.59	10,000	2,685,900		Apr 28 09:53 AM
Sauerland John P	VP and Chief Financial Officer	Mar 28 '25	Sale	275.94	10,000	2,759,400	258,024	Mar 31 01:39 PM
Sauerland John P	Officer	Mar 28 '25	Proposed Sale	275.94	10,000	2,759,400		Mar 28 11:09 AM
Johnson Devin C	Director	Mar 25 '25	Sale	275.04	400	110,016	8,370	Mar 26 02:52 PM
Johnson Devin C	Director	Mar 25 '25	Proposed Sale	275.04	400	110,016		Mar 25 10:36 AM
Joyce Carl G	Chief Accounting Officer	Mar 21 '25	Sale	276.17	360	99,420	655	Mar 24 11:59 AM
Joyce Carl G	Officer	Mar 21 '25	Proposed Sale	276.17	360	99,420		Mar 21 01:16 PM
Sauerland John P	VP and Chief Financial Officer	Mar 17 '25	Sale	282.66	1,542	435,862	268,024	Mar 18 11:37 AM
Bauer Jonathan S.	Chief Investment Officer	Mar 17 '25	Sale	282.66	1,696	479,391	26,697	Mar 18 11:25 AM
Sauerland John P	Officer	Mar 17 '25	Proposed Sale	282.66	1,542	435,862		Mar 17 10:06 AM
Bauer Jonathan S.	Officer	Mar 17 '25	Proposed Sale	282.66	1,696	479,391		Mar 17 09:55 AM

Open in Screener

GWRE

Guidewire Software Inc

Mar 10 • 04:00PM ET

158.93

-4.37 -2.68 %

Technology • Software - Application • USA • NYSE

GWRE Guidewire Software Inc daily Stock Chart

Peers: MSFT ACN ORCL NOW ADBE CRM INTU SNOW TEAM TWLO

| Held by: IJH VTI VB VBK VGT VXF MDY IWP XMMO IJK

Index	-	P/E	72.31	EPS (ttm)	2.20	Insider Own	0.68%	Shs Outstand	84.66M	Perf Week	4.61%
Market Cap	13.45B	Forward P/E	37.31	EPS next Y	4.26	Insider Trans	-20.80%	Shs Float	84.09M	Perf Month	23.98%
Enterprise Value	13.24B	PEG	1.40	EPS next Q	0.74	Inst Own	99.39%	Short Float	4.41%	Perf Quarter	-24.52%
Income	189.36M	P/S	10.03	EPS this Y	32.68%	Inst Trans	-1.43%	Short Ratio	2.21	Perf Half Y	-39.31%
Sales	1.34B	P/B	8.91	EPS next Y	21.17%	ROA	7.24%	Short Interest	3.71M	Perf YTD	-20.93%
Book/sh	17.84	P/C	14.64	EPS next 5Y	26.74%	ROE	13.63%	52W High	272.60 -41.70%	Perf Year	-4.68%
Cash/sh	10.86	P/FCF	45.79	EPS past 3/5Y	- -	ROIC	8.55%	52W Low	120.37 32.03%	Perf 3Y	122.28%
Dividend Est.	-	EV/EBITDA	91.42	Sales past 3/5Y	13.95% 10.13%	Gross Margin	63.76%	Volatility	5.71% 5.85%	Perf 5Y	57.15%
Dividend TTM	-	EV/Sales	9.87	EPS Y/Y TTM	1221.98%	Oper. Margin	6.84%	ATR (14)	8.43	Perf 10Y	208.96%
Dividend Ex-Date	-	Quick Ratio	2.89	Sales Y/Y TTM	23.72%	Profit Margin	14.11%	RSI (14)	58.56	Recom	1.47
Dividend Gr. 3/5Y	- -	Current Ratio	2.89	EPS Q/Q	256.75%	SMA20	13.28%	Beta	1.07	Target Price	241.50
Payout	0.00%	Debt/Eq	0.47	Sales Q/Q	24.05%	SMA50	2.20%	Rel Volume	1.10	Prev Close	163.30
Employees	3772	LT Debt/Eq	0.47	Earnings	Mar 05 AMC	SMA200	-23.96%	Avg Volume	1.68M	Price	158.93
IPO	Jan 25, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	51.42% 4.76%	Trades		Volume	1,924,316	Change	-2.68%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-25	Upgrade	DA Davidson	Neutral → Buy	$250
May-22-25	Downgrade	DA Davidson	Buy → Neutral	$226
Jan-23-25	Initiated	Goldman	Buy	$210
Feb-01-24	Initiated	Raymond James	Outperform	$125
Dec-20-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Dec-08-23	Reiterated	Oppenheimer	Outperform	$100 → $115
Nov-14-23	Upgrade	Robert W. Baird	Neutral → Outperform	$96 → $117
Aug-31-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$65 → $85
Jun-27-23	Upgrade	Stifel	Hold → Buy	$75 → $85
Jan-23-23	Initiated	Goldman	Buy	$88
Dec-01-22	Initiated	JP Morgan	Overweight	$78
Jul-27-22	Initiated	Oppenheimer	Outperform	$85
Apr-19-22	Initiated	RBC Capital Mkts	Outperform	$125
Mar-18-22	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$110
Oct-04-21	Downgrade	BofA Securities	Neutral → Underperform	$132 → $125
Jul-16-21	Resumed	Stifel	Hold	$110
Jul-13-21	Resumed	JP Morgan	Overweight	$145
Jun-16-21	Downgrade	Needham	Buy → Hold
Jun-04-21	Resumed	DA Davidson	Buy	$144 → $124
Jun-03-21	Reiterated	Needham	Buy	$125 → $120

Show Previous Ratings

Mar-10-26 09:15AM	International Markets and Guidewire Software (GWRE): A Deep Dive for Investors (Zacks)
Mar-09-26 09:34AM	Company News for Mar 9, 2026 (Zacks)
Mar-08-26 11:30AM	The Trade Desk, Circle, And Venture Global Are Among the Top 10 Large-Cap Gainers Last Week (March 2-March 6): Are the Others in Your Portfolio? (Benzinga)
Mar-06-26 03:50PM	Guidewire Software (GWRE) Shares Skyrocket, What You Need To Know (StockStory)
12:36PM	Tech, Media & Telecom Roundup: Market Talk (The Wall Street Journal)
10:28AM	Loading…
10:28AM	Guidewire Q2 Earnings & Revenues Beat Estimates, Up Y/Y, Stock Rises (Zacks)
09:01AM	GWRE Q4 Deep Dive: Cloud Momentum and AI Tailwinds Shape Upbeat Outlook (StockStory)
08:45AM	These Stocks Are Todays Movers: Marvell, Gap, United Airlines, Corning, Guidewire, Nutex, Samsara, and More (Barrons.com)
08:30AM	Guidewire Software, Inc. Q2 2026 Earnings Call Summary (Moby)
08:22AM	Guidewire Raises Outlook After Strong Quarter (Benzinga)
05:40AM	These Stocks Are Today's Movers: Marvell, Gap, Costco, Guidewire, Nutex, and More (Barrons.com)
03:53AM	Guidewire Software Q2 Earnings Call Highlights (MarketBeat)
12:01AM	Guidewire Software Inc (GWRE) Q2 2026 Earnings Call Highlights: Strong ARR Growth and Cloud ... (GuruFocus.com)
Mar-05-26 10:52PM	Analyst Report: Guidewire Software, Inc. (Morningstar Research)
06:00PM	Guidewire Software (GWRE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:50PM	Loading…
05:50PM	Guidewire Software (GWRE) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:39PM	Guidewire Software: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:28PM	Guidewire Software's (NYSE:GWRE) Q4 CY2025: Strong Sales (StockStory)
04:20PM	Guidewire Software's (NYSE:GWRE) Q4 CY2025 Sales Top Estimates (StockStory)
04:05PM	Guidewire Announces Second Quarter Fiscal Year 2026 Financial Results (Business Wire)
05:36AM	Costco and Marvell Tech. headline earnings (MarketWatch)
04:29AM	Stock Market Today: Dow, S&P 500 and Nasdaq inch lower as equities consolidate after latest rally; Broadcom up after earnings; oil holds near highs; Korean stocks bounce back. (MarketWatch)
Mar-04-26 06:45PM	Analyst Report: Guidewire Software, Inc. (Morningstar Research)
Mar-03-26 10:06PM	Earnings To Watch: Guidewire Software (GWRE) Reports Q4 Results Tomorrow (StockStory)
12:49AM	Oppenheimer Maintains Overweight Rating on Guidewire (GWRE) (Insider Monkey)
Mar-02-26 09:15AM	Curious about Guidewire Software (GWRE) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Mar-01-26 06:00AM	What to Expect in Markets This Week: Investors Watching Developments in Iran, Awaiting Jobs Report, Other Economic Data, Earnings Reports (Investopedia)
Feb-28-26 07:30AM	These fintech stocks are loved by analysts and could bounce back in a big way (MarketWatch)
Feb-27-26 06:26AM	Guidewire Software (GWRE) Moves 6.0% Higher: Will This Strength Last? (Zacks)
Feb-26-26 08:43AM	Guidewire Software, Inc. (GWRE) Stock Could More Than Double From Here According To Analysts (Insider Monkey) +6.03%
11:41PM	Loading…
Feb-25-26 11:41PM	2 Cash-Heavy Stocks to Target This Week and 1 We Find Risky (StockStory) +6.05%
07:05PM	BTIG Cautious on Guidewire Software (GWRE) Amid Software Sector Headwinds (Insider Monkey)
Feb-20-26 11:36AM	Guidwire (GWRE) Offers Impressive Upside Following a New Buyback Program (Insider Monkey)
Feb-19-26 04:15PM	Guidewire to Announce Second Quarter Fiscal Year 2026 Financial Results on March 5, 2026 (Business Wire)
03:08AM	London Market Brokers Favouring Digitally Advanced Insurers in a Softening Market (Business Wire)
Feb-18-26 03:55PM	Why Is Guidewire Software (GWRE) Stock Rocketing Higher Today (StockStory) +5.36%
08:53AM	Guidewire Wins Long-Term Deal To Modernize Sompo's Worldwide Operations (Benzinga)
Feb-17-26 11:06PM	2 Reasons to Like GWRE (and 1 Not So Much) (StockStory)
02:30PM	JPMorgan Flags 'AI-Resilient' Software Names After Selloff (Benzinga)
Feb-16-26 11:32PM	2 of Wall Street's Favorite Stocks to Consider Right Now and 1 Facing Challenges (StockStory)
Feb-14-26 01:20AM	Guidewire Software (GWRE): Wells Fargo Identifies AI, Secular Trends as Primary 2026 Performance Drivers (Insider Monkey)
Feb-13-26 07:26AM	JPMorgan Flags 'AI-Resilient' Software Names After Selloff (Benzinga)
Feb-12-26 05:40PM	JFrog Ltd. (FROG) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-11-26 11:32PM	2 Oversold Stocks Set for a Comeback and 1 We Turn Down (StockStory)
Feb-10-26 11:12AM	Microsoft, CrowdStrike, and 17 Software Stocks That Can Survive AI (Barrons.com) +5.91%
Feb-05-26 11:33PM	2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Ignore (StockStory)
Feb-04-26 01:12PM	The Software Crash In Numbers: These Stocks Are Getting Hit Hardest (Benzinga)
Feb-03-26 11:45AM	Why Guidewire Software (GWRE) Stock Is Nosediving (StockStory) -6.67%
Feb-02-26 08:10PM	Analyst Report: Guidewire Software, Inc. (Morningstar Research)
Jan-30-26 02:51PM	These 10 Stocks Just Had Their Best Or Worst Month Ever - And You Might Not Know Why (Benzinga)
Jan-27-26 02:31AM	NFU Mutual to Further Improve Customer Service by Moving to Guidewire Cloud Platform (Business Wire)
Jan-26-26 11:36PM	2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore (StockStory)
Jan-22-26 10:32PM	Q3 Earnings Roundup: Guidewire Software (NYSE:GWRE) And The Rest Of The Vertical Software Segment (StockStory)
Jan-21-26 10:32PM	Q3 Earnings Highs And Lows: Guidewire Software (NYSE:GWRE) Vs The Rest Of The Vertical Software Stocks (StockStory)
Jan-20-26 10:27AM	Guidewire Slips 12% in a Year: How to Approach the Stock Now? (Zacks)
Jan-19-26 04:19AM	Why is Guidewire Software (GWRE) One of the Best Strong Buy Growth Stocks to Buy According to Hedge Funds? (Insider Monkey)
Jan-18-26 12:31PM	Trip.com, Regencell Bioscience, And Atlassian Are Among Top 10 Large Cap Losers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio? (Benzinga)
07:35AM	Here is Why Guidewire Software (GWRE) is Highly Favored by Hedge Funds (Insider Monkey)
Jan-16-26 01:28PM	Guidewire's Buyback Could Be the Clue the Sell-Off Is Ending (MarketBeat)
Jan-14-26 03:05PM	Guidewire Software, American Express Global Business Travel, Appian, Braze, and Fastly Shares Plummet, What You Need To Know (StockStory)
Jan-13-26 08:29AM	Down 20%+, These 3 Software Stocks Are Boosting Buybacks (MarketBeat)
05:21AM	Vaudoise Becomes First Swiss Insurer to Go-Live with Guidewire Cloud Platform (Business Wire)
Jan-09-26 11:31AM	Guidewire Software (GWRE) Stock Trades Up, Here Is Why (StockStory)
07:25AM	SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales (Zacks)
Jan-08-26 07:00PM	Analyst Report: Guidewire Software, Inc. (Morningstar Research)
05:14PM	Guidewire Announces $500.0 Million Share Repurchase Program and Completion of Prior Authorization (Business Wire)
Jan-02-26 10:48AM	Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. (Barrons.com) -6.66%
Dec-19-25 11:10AM	JPMorgan Highlights 11 Tech Stocks for 2026 (GuruFocus.com)
10:19AM	BlackBerry Q3 Earnings & Revenues Beat Estimates Despite Headwinds (Zacks)
Dec-18-25 11:38PM	1 Cash-Producing Stock Worth Investigating and 2 We Question (StockStory)
Dec-17-25 09:33AM	Spotify initiated, Airbnb upgraded: Wall Street's top analyst calls (The Fly)
08:58AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Ally Financial, CyberArk, Fortinet, Robinhood Markets, Salesforce, ServiceNow, Procter & Gamble, and More (24/7 Wall St.)
Dec-11-25 05:16PM	Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally (MarketBeat)
Dec-10-25 12:31AM	Guidewire Software's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Dec-09-25 07:14AM	Guidewire Olos Boosts Pricing Speed and Workers' Compensation Outcomes (Zacks)
Dec-08-25 09:23AM	AI Is Powering Guidewire Software's Growth-So What Spooked the Market? (MarketBeat)
09:15AM	Guidewire Software (GWRE) Reliance on International Sales: What Investors Need to Know (Zacks)
08:55AM	Guidewire Olos Release Powers Intelligent Pricing, Drives Faster Rate Changes, and Enhances Workers Compensation Performance (Business Wire)
Dec-07-25 10:21AM	Rubrik's Massive Rebound: Why the Next Leg Higher Could Be Fast (MarketBeat)
Dec-05-25 02:35PM	Snowflake Stock: The Dip That Smart Investors Are Buying Right Now (MarketBeat)
12:27PM	Guidewire Supports Cincinnati Insurance to Transform Claims Operations (Zacks)
Dec-04-25 06:05PM	Guidewire Software Inc (GWRE) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
04:56PM	Guidewire Software (GWRE) Stock Trades Down, Here Is Why (StockStory)
09:30AM	Compared to Estimates, Guidewire Software (GWRE) Q1 Earnings: A Look at Key Metrics (Zacks)
09:04AM	Guidewire Q1 Earnings Match Estimates, Revenues Increase Y/Y (Zacks)
08:55AM	The Cincinnati Insurance Company Deploys Guidewire ClaimCenter to Transform Claims Operations (Business Wire)
08:33AM	Analyst Report: Guidewire Software, Inc. (Morningstar Research)
12:31AM	GWRE Q3 Deep Dive: Cloud Expansion, New Products, and AI Adoption Fuel Growth (StockStory)
Dec-03-25 06:04PM	Guidewire Software: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
05:25PM	Guidewire Software (GWRE) Q1 Earnings Match Estimates (Zacks)
04:47PM	Guidewire Software's (NYSE:GWRE) Q3 CY2025: Beats On Revenue (StockStory)
04:15PM	Guidewire Announces First Quarter Fiscal Year 2026 Financial Results (Business Wire)
09:41AM	Salesforces Stock Is Historically Cheap as AI Risk Takes a Toll (Bloomberg)
Dec-02-25 10:22AM	Guidewire to Report Q1 Earnings: Here's What Investors Should Know (Zacks)
Dec-01-25 10:02PM	Guidewire Software Earnings: What To Look For From GWRE (StockStory)
Nov-27-25 09:15AM	Insights Into Guidewire Software (GWRE) Q1: Wall Street Projections for Key Metrics (Zacks)
Nov-21-25 09:09AM	2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky (StockStory)
Nov-20-25 05:15PM	Elastic (ESTC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Nov-19-25 04:15PM	Guidewire to Announce First Quarter Fiscal Year 2026 Financial Results on December 3, 2025 (Business Wire)
Nov-14-25 08:39AM	The Zacks Analyst Blog Highlights NVIDIA, Dell Technologies, Palantir Technologies, Fair Isaac and Guidewire Software (Zacks)

Guidewire Software, Inc. is engaged in the provision of a technology platform, which combines core systems of record with digital, analytics, and artificial intelligence applications. The firm offers the following suite of products: Guidewire InsuranceSuite and Guidewire InsuranceNow. The Guidewire InsuranceSuite is a configurable and scalable product, delivered as a service, and primarily consisting of three core applications, such as PolicyCenter, ClaimCenter, and BillingCenter, that can be subscribed separately or together. InsuranceNow is a complete, cloud-based application that offers policy administration, claims management, and billing functionality, plus pre-integrated document production, analytics, and other capabilities. The company was founded by Marcus S. Ryu on September 20, 2001 and is headquartered in San Mateo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosenbaum Michael George	Chief Executive Officer	Mar 09 '26	Sale	166.34	1,200	199,608	227,143	Mar 09 08:59 PM
MIKE ROSENBAUM	Officer	Mar 09 '26	Proposed Sale	166.34	1,200	199,608		Mar 09 04:01 PM
Rosenbaum Michael George	Chief Executive Officer	Mar 02 '26	Sale	143.87	1,200	172,644	228,343	Mar 03 05:24 PM
MIKE ROSENBAUM	Officer	Mar 02 '26	Proposed Sale	143.87	1,200	172,644		Mar 02 04:10 PM
Rosenbaum Michael George	Chief Executive Officer	Feb 23 '26	Sale	125.50	1,200	150,600	229,543	Feb 23 05:32 PM
MIKE ROSENBAUM	Officer	Feb 23 '26	Proposed Sale	125.50	1,200	150,600		Feb 23 04:30 PM
Rosenbaum Michael George	Chief Executive Officer	Feb 17 '26	Sale	127.00	1,200	152,400	230,743	Feb 17 06:38 PM
MIKE ROSENBAUM	Officer	Feb 17 '26	Proposed Sale	127.00	1,200	152,400		Feb 17 04:06 PM
Rosenbaum Michael George	Chief Executive Officer	Feb 09 '26	Sale	127.77	1,200	153,324	231,943	Feb 10 04:48 PM
MIKE ROSENBAUM	Officer	Feb 09 '26	Proposed Sale	127.77	1,200	153,324		Feb 09 04:05 PM
Lavin Paul	Former Director	Feb 04 '26	Proposed Sale	125.64	4,878	612,872		Feb 04 03:35 PM
Rosenbaum Michael George	Chief Executive Officer	Feb 02 '26	Sale	140.01	1,200	168,012	233,143	Feb 03 06:05 PM
MIKE ROSENBAUM	Officer	Feb 02 '26	Proposed Sale	140.01	1,200	168,012		Feb 02 04:03 PM
Rosenbaum Michael George	Chief Executive Officer	Jan 26 '26	Sale	160.32	1,200	192,384	234,343	Jan 26 07:43 PM
MIKE ROSENBAUM	Officer	Jan 26 '26	Proposed Sale	160.32	1,200	192,384		Jan 26 04:03 PM
Rosenbaum Michael George	Chief Executive Officer	Jan 20 '26	Sale	156.26	1,200	187,512	235,543	Jan 22 12:29 PM
MIKE ROSENBAUM	Officer	Jan 20 '26	Proposed Sale	156.26	1,200	187,512		Jan 20 04:02 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Jan 13 '26	Sale	180.87	216	39,068	72,753	Jan 15 04:41 PM
Rosenbaum Michael George	Chief Executive Officer	Jan 13 '26	Sale	180.87	1,200	217,044	236,743	Jan 15 04:40 PM
JEFFREY COOPER	Officer	Jan 13 '26	Proposed Sale	180.87	216	39,068		Jan 13 04:07 PM
MIKE ROSENBAUM	Officer	Jan 13 '26	Proposed Sale	180.87	1,200	217,044		Jan 13 04:05 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 29 '25	Sale	204.95	1,400	286,930	237,943	Dec 29 09:47 PM
MIKE ROSENBAUM	Officer	Dec 29 '25	Proposed Sale	204.95	1,400	286,930		Dec 29 04:01 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 22 '25	Sale	200.72	1,400	281,008	239,343	Dec 22 04:10 PM
MIKE ROSENBAUM	Officer	Dec 22 '25	Proposed Sale	200.72	1,400	281,008		Dec 22 04:01 PM
JEFFREY COOPER	Officer	Dec 18 '25	Proposed Sale	195.00	1,232	240,240		Dec 18 04:09 PM
JAMES W KING	Officer	Dec 18 '25	Proposed Sale	195.00	1,860	362,700		Dec 18 04:08 PM
King James Winston	Chief Admin Officer, Gen Couns	Dec 18 '25	Sale	195.00	1,860	362,700	33,702	Dec 18 04:04 PM
King James Winston	Chief Admin Officer, Gen Couns	Dec 16 '25	Sale	192.08	1,457	279,855	35,562	Dec 18 04:04 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Dec 16 '25	Sale	192.08	2,872	551,643	74,201	Dec 18 04:04 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Dec 18 '25	Sale	195.00	1,232	240,240	72,969	Dec 18 04:04 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 16 '25	Sale	192.08	6,015	1,155,338	240,743	Dec 17 05:39 PM
Peterson David Franklin	Chief Accounting Officer	Dec 16 '25	Sale	192.08	358	68,763	12,806	Dec 17 05:39 PM
Mullen John P	President	Dec 16 '25	Sale	192.08	7,975	1,531,807	141,983	Dec 17 05:39 PM
David Franklin Peterson	Chief Accounting Officer	Dec 16 '25	Proposed Sale	192.08	358	68,763		Dec 16 07:19 PM
James Winston King	Chief Admin Officer and Genera	Dec 16 '25	Proposed Sale	192.08	1,457	279,855		Dec 16 07:18 PM
John P Mullen	President	Dec 16 '25	Proposed Sale	192.08	7,975	1,531,807		Dec 16 07:17 PM
Michael George Rosenbaum	Chief Executive Officer	Dec 16 '25	Proposed Sale	192.08	6,015	1,155,338		Dec 16 07:16 PM
Jeffrey Elliott Cooper	Chief Financial Officer	Dec 16 '25	Proposed Sale	192.08	2,872	551,643		Dec 16 07:15 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 15 '25	Sale	204.34	1,400	286,076	246,758	Dec 15 06:09 PM
MIKE ROSENBAUM	Officer	Dec 15 '25	Proposed Sale	204.34	1,400	286,076		Dec 15 04:04 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 08 '25	Sale	210.87	1,400	295,218	248,158	Dec 08 05:19 PM
MIKE ROSENBAUM	Officer	Dec 08 '25	Proposed Sale	210.87	1,400	295,218		Dec 08 04:28 PM
Mullen John P	President	Dec 01 '25	Sale	213.44	3,000	640,320	149,958	Dec 01 05:55 PM
Rosenbaum Michael George	Chief Executive Officer	Dec 01 '25	Sale	213.44	1,400	298,816	249,558	Dec 01 05:55 PM
MIKE ROSENBAUM	Officer	Dec 01 '25	Proposed Sale	213.44	1,400	298,816		Dec 01 04:07 PM
JOHN MULLEN	Officer	Dec 01 '25	Proposed Sale	213.44	3,000	640,320		Dec 01 04:02 PM
Rosenbaum Michael George	Chief Executive Officer	Nov 24 '25	Sale	213.23	1,400	298,522	250,958	Nov 24 04:06 PM
MIKE ROSENBAUM	Officer	Nov 24 '25	Proposed Sale	213.23	1,400	298,522		Nov 24 04:03 PM
Rosenbaum Michael George	Chief Executive Officer	Nov 17 '25	Sale	222.54	1,400	311,556	252,358	Nov 17 06:19 PM
King James Winston	Chief Admin Officer, Gen Couns	Nov 17 '25	Sale	222.54	798	177,587	37,019	Nov 17 06:19 PM
MIKE ROSENBAUM	Officer	Nov 17 '25	Proposed Sale	222.54	1,400	311,556		Nov 17 04:05 PM
JAMES W KING	Officer	Nov 17 '25	Proposed Sale	222.54	798	177,587		Nov 17 04:05 PM
Rosenbaum Michael George	Chief Executive Officer	Nov 10 '25	Sale	218.53	1,400	305,942	253,758	Nov 10 05:00 PM
MIKE ROSENBAUM	Officer	Nov 10 '25	Proposed Sale	218.53	1,400	305,942		Nov 10 04:01 PM
Rosenbaum Michael George	Chief Executive Officer	Nov 03 '25	Sale	231.85	1,400	324,590	255,158	Nov 03 08:03 PM
Mullen John P	President	Nov 03 '25	Sale	231.85	3,000	695,550	152,958	Nov 03 08:01 PM
MIKE ROSENBAUM	Officer	Nov 03 '25	Proposed Sale	231.85	1,400	324,590		Nov 03 04:07 PM
JOHN MULLEN	Officer	Nov 03 '25	Proposed Sale	231.85	3,000	695,550		Nov 03 04:02 PM
Rosenbaum Michael George	Chief Executive Officer	Oct 27 '25	Sale	255.40	1,400	357,560	256,558	Oct 27 05:01 PM
MIKE ROSENBAUM	Officer	Oct 27 '25	Proposed Sale	255.40	1,400	357,560		Oct 27 04:00 PM
Rosenbaum Michael George	Chief Executive Officer	Oct 20 '25	Sale	245.70	1,400	343,980	257,958	Oct 21 04:08 PM
King James Winston	Chief Admin Officer, Gen Couns	Oct 20 '25	Sale	245.70	798	196,069	37,817	Oct 21 04:04 PM
MIKE ROSENBAUM	Officer	Oct 20 '25	Proposed Sale	245.70	1,400	343,980		Oct 20 04:06 PM
JAMES W KING	Officer	Oct 20 '25	Proposed Sale	245.70	798	196,069		Oct 20 04:05 PM
Rosenbaum Michael George	Chief Executive Officer	Oct 13 '25	Sale	239.71	1,400	335,594	259,358	Oct 14 02:25 PM
MIKE ROSENBAUM	Officer	Oct 13 '25	Proposed Sale	239.71	1,400	335,594		Oct 14 08:55 AM
Rosenbaum Michael George	Chief Executive Officer	Oct 06 '25	Sale	230.08	1,400	322,112	260,758	Oct 06 07:15 PM
MIKE ROSENBAUM	Officer	Oct 06 '25	Proposed Sale	230.08	1,400	322,112		Oct 06 04:23 PM
Mullen John P	President	Oct 01 '25	Sale	230.73	3,000	692,190	155,958	Oct 01 05:03 PM
Bauer David S	Director	Oct 01 '25	Sale	230.73	500	115,365	5,903	Oct 01 04:52 PM
JOHN MULLEN	Officer	Oct 01 '25	Proposed Sale	230.73	3,000	692,190		Oct 01 04:02 PM
DAVID S BAUER	Director	Oct 01 '25	Proposed Sale	230.73	500	115,365		Oct 01 04:01 PM
Rosenbaum Michael George	Chief Executive Officer	Sep 29 '25	Sale	232.25	1,400	325,150	262,158	Sep 29 04:30 PM
MIKE ROSENBAUM	Officer	Sep 29 '25	Proposed Sale	232.25	1,400	325,150		Sep 29 04:05 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Sep 18 '25	Sale	248.76	7,535	1,874,377	77,111	Sep 22 07:32 PM
King James Winston	Chief Admin Officer, Gen Couns	Sep 18 '25	Sale	248.82	7,162	1,782,059	38,615	Sep 22 07:32 PM
Peterson David Franklin	Chief Accounting Officer	Sep 18 '25	Sale	249.86	1,000	249,860	13,164	Sep 22 07:24 PM
Rosenbaum Michael George	Chief Executive Officer	Sep 22 '25	Sale	244.55	1,400	342,370	263,558	Sep 22 07:24 PM
MIKE ROSENBAUM	Officer	Sep 22 '25	Proposed Sale	244.55	1,400	342,370		Sep 22 04:01 PM
JAMES W KING	Officer	Sep 18 '25	Proposed Sale	248.82	7,162	1,782,059		Sep 18 04:27 PM
DAVID F PETERSON	Officer	Sep 18 '25	Proposed Sale	249.86	1,000	249,860		Sep 18 04:24 PM
JEFFREY COOPER	Officer	Sep 18 '25	Proposed Sale	248.76	7,535	1,874,377		Sep 18 04:08 PM
King James Winston	Chief Admin Officer, Gen Couns	Sep 15 '25	Option Exercise	0.00	10,597	0	52,926	Sep 17 07:27 PM
King James Winston	Chief Admin Officer, Gen Couns	Sep 16 '25	Sale	242.87	7,149	1,736,256	45,777	Sep 17 07:27 PM
Peterson David Franklin	Chief Accounting Officer	Sep 15 '25	Option Exercise	0.00	3,179	0	15,975	Sep 17 07:27 PM
Peterson David Franklin	Chief Accounting Officer	Sep 16 '25	Sale	242.87	1,811	439,833	14,164	Sep 17 07:27 PM
Mullen John P	President	Sep 15 '25	Option Exercise	0.00	18,543	0	174,827	Sep 17 07:27 PM
Mullen John P	President	Sep 16 '25	Sale	242.87	15,869	3,854,055	158,958	Sep 17 07:27 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Sep 15 '25	Option Exercise	0.00	21,194	0	98,749	Sep 17 07:27 PM
Cooper Jeffrey Elliott	Chief Financial Officer	Sep 16 '25	Sale	242.87	14,103	3,425,150	84,646	Sep 17 07:27 PM
Rosenbaum Michael George	Chief Executive Officer	Sep 15 '25	Option Exercise	0.00	45,849	0	295,275	Sep 17 07:26 PM
Rosenbaum Michael George	Chief Executive Officer	Sep 16 '25	Sale	242.87	30,317	7,362,965	264,958	Sep 17 07:26 PM
Michael George Rosenbaum	Chief Executive Officer	Sep 16 '25	Proposed Sale	242.87	30,317	7,362,965		Sep 16 09:33 PM
Jeffrey Elliott Cooper	Chief Financial Officer	Sep 16 '25	Proposed Sale	242.87	14,103	3,425,150		Sep 16 09:31 PM
John P Mullen	President	Sep 16 '25	Proposed Sale	242.87	15,869	3,854,054		Sep 16 09:30 PM
James Winston King	Chief Admin Officer and Genera	Sep 16 '25	Proposed Sale	242.87	7,149	1,736,256		Sep 16 09:28 PM
David Franklin Peterson	Chief Accounting Officer	Sep 16 '25	Proposed Sale	242.87	1,811	439,833		Sep 16 09:26 PM
Rosenbaum Michael George	Chief Executive Officer	Sep 15 '25	Sale	252.83	1,400	353,962	249,426	Sep 15 06:06 PM
MIKE ROSENBAUM	Officer	Sep 15 '25	Proposed Sale	252.83	1,400	353,962		Sep 15 04:49 PM

Open in Screener

OGEN

Oragenics Inc

Mar 10 • 04:00PM ET

0.9816

+0.0214 2.23 %

Healthcare • Biotechnology • USA • AMEX

Peers: CTXR VNRX DSGN CTSO AIM PAVM OTLK AYTU HOTH AVGR

Index	-	P/E	-	EPS (ttm)	-16.71	Insider Own	0.66%	Shs Outstand	4.17M	Perf Week	18.34%
Market Cap	4.09M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.76%	Shs Float	4.14M	Perf Month	34.10%
Enterprise Value	-6.92M	PEG	-	EPS next Q	-	Inst Own	5.18%	Short Float	13.77%	Perf Quarter	11.10%
Income	-10.90M	P/S	-	EPS this Y	-	Inst Trans	2.59%	Short Ratio	1.16	Perf Half Y	-16.10%
Sales	0.00M	P/B	0.41	EPS next Y	-	ROA	-121.78%	Short Interest	0.57M	Perf YTD	25.33%
Book/sh	2.38	P/C	0.36	EPS next 5Y	-	ROE	-168.95%	52W High	9.60 -89.78%	Perf Year	-88.52%
Cash/sh	2.74	P/FCF	-	EPS past 3/5Y	42.39% 40.88%	ROIC	-110.92%	52W Low	0.61 60.63%	Perf 3Y	-99.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.24% 11.79%	Perf 5Y	-99.95%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	90.27%	Oper. Margin	-	ATR (14)	0.09	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	4.42	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	67.41	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.42	EPS Q/Q	82.64%	SMA20	26.36%	Beta	1.05	Target Price	2.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	20.45%	Rel Volume	0.66	Prev Close	0.96
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-34.27%	Avg Volume	489.60K	Price	0.98
IPO	Oct 21, 2003	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	350,413	Change	2.23%

Today 08:30AM	ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION (GlobeNewswire)
Mar-10-26 08:30AM	Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia (GlobeNewswire)
Feb-10-26 08:46AM	Oragenics previews targeted milestones for 2026 (TipRanks)
Feb-09-26 08:30AM	Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy (GlobeNewswire) -5.18%
Feb-04-26 08:40AM	Oragenics partners with Duck Flats Pharma to support FDA IND trial design (TipRanks)
08:30AM	Loading…
Feb-03-26 08:30AM	Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program (GlobeNewswire) -7.23%
Feb-02-26 08:30AM	Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care (GlobeNewswire)
Jan-14-26 08:30AM	Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico (GlobeNewswire)
Nov-07-25 04:26PM	Oragenics: Q3 Earnings Snapshot (Associated Press Finance)
Oct-08-25 05:13AM	Oragenics partners Receptor.AI for brain health candidate portfolio (Pharmaceutical Technology)
Aug-11-25 08:45AM	Oragenics Q2 2025 Shareholder Update (GlobeNewswire)
Aug-08-25 04:33PM	Oragenics: Q2 Earnings Snapshot (Associated Press Finance) -10.77%
Aug-01-25 06:55AM	Oragenics partners with Southern Star Research for Phase IIa trial of ONP-002 (Clinical Trials Arena)
Jul-31-25 08:30AM	Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial (GlobeNewswire)
Jul-16-25 08:39AM	Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development (GlobeNewswire) +5.97%
04:15PM	Loading…
Jul-02-25 04:15PM	Oragenics Completes Approximately $16.5 Million Offering (GlobeNewswire) -7.10% +6.25%
Jul-01-25 08:31AM	Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants (GlobeNewswire) -59.42%
Jun-10-25 08:30AM	Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium (GlobeNewswire)
May-28-25 07:00AM	Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split (GlobeNewswire) -27.76%
May-13-25 08:30AM	Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia (GlobeNewswire) +8.89%
May-12-25 08:30AM	Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision (GlobeNewswire) +6.76%
May-09-25 04:38PM	Oragenics: Q1 Earnings Snapshot (Associated Press Finance) -6.33%
Apr-23-25 08:30AM	Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference (GlobeNewswire)
Apr-09-25 08:58AM	Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial (GlobeNewswire) +6.68%
Apr-07-25 04:30PM	Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit (GlobeNewswire) -7.05%
Mar-27-25 08:30AM	Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress (GlobeNewswire)
Mar-18-25 05:33PM	Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K (GlobeNewswire)
Mar-06-25 09:30AM	Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI) (GlobeNewswire)
Feb-25-25 08:30AM	Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment (GlobeNewswire)
Feb-24-25 08:30AM	Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health (GlobeNewswire)
08:30AM	Loading…
Feb-11-25 08:30AM	Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment (GlobeNewswire) -6.78%
Feb-05-25 08:15AM	Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 (GlobeNewswire)
Jan-21-25 08:15AM	Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO (GlobeNewswire)
Dec-16-24 08:09AM	Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference (GlobeNewswire) +5.91%
Oct-18-24 08:30AM	Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit (GlobeNewswire)
Oct-09-24 07:30AM	Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation (GlobeNewswire) +6.39%
Oct-08-24 08:45AM	Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002 (GlobeNewswire) -9.21%
08:30AM	EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate (Benzinga)
Sep-05-24 04:30PM	Oragenics, Inc. Announces Closing of Public Offering (GlobeNewswire) -8.81%
Sep-04-24 08:36AM	Oragenics, Inc. Announces Pricing of Public Offering (GlobeNewswire) -46.20%
Aug-21-24 08:45AM	Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients (GlobeNewswire)
Aug-16-24 04:30PM	Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards (GlobeNewswire) -21.53% -9.73%
Aug-14-24 08:30AM	Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range (GlobeNewswire) -19.28%
Aug-12-24 08:30AM	Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study (GlobeNewswire) +48.57%
Aug-09-24 04:43PM	Oragenics: Q2 Earnings Snapshot (Associated Press Finance) +29.63%
09:00AM	As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032 (PR Newswire)
Aug-08-24 08:45AM	Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing (GlobeNewswire) +11.74%
08:30AM	EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase II Trials Underway (Benzinga)
Jul-10-24 08:00AM	Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients (GlobeNewswire) +11.32%
Jun-27-24 08:30AM	Oragenics Develops Automated Intranasal Device for Treating Concussed Patients (GlobeNewswire)
Jun-26-24 04:47PM	Oragenics, Inc. Announces Closing of Public Offering (GlobeNewswire)
Jun-25-24 08:30AM	Oragenics, Inc. Announces Pricing of Public Offering (GlobeNewswire) -23.37%
Jun-24-24 06:43PM	Oragenics, Inc. Announces Proposed Public Offering (GlobeNewswire) -9.38%
Jun-20-24 08:00AM	Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance (GlobeNewswire) -5.23%
May-22-24 08:00AM	Oragenics Appoints William Frank Peacock MD as Chief Clinical Officer (GlobeNewswire) -17.43%
May-17-24 08:00AM	Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine (GlobeNewswire) +42.07%
May-16-24 12:52PM	Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise (MT Newswires)
08:00AM	Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial (GlobeNewswire)
May-15-24 01:07PM	Oragenics: Q1 Earnings Snapshot (Associated Press Finance)
May-07-24 08:00AM	Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia (GlobeNewswire) +24.07%
Apr-19-24 05:50PM	Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards (Business Wire) -6.19%
Apr-01-24 09:05AM	Oragenics, Inc. Files 10K and Provides Company Update (Business Wire)
Mar-18-24 07:00AM	Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion (Business Wire)
Mar-17-24 08:38AM	15 Highest Quality Probiotics For Gut Health (Insider Monkey)
Mar-05-24 07:45AM	Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion (Business Wire)
Mar-01-24 04:04PM	Oragenics Announces Closing of Public Offering (Business Wire)
Feb-27-24 09:25PM	Oragenics Announces Pricing of Public Offering (Business Wire) -22.47% -42.04%
04:33PM	Oragenics Announces Proposed Public Offering (Business Wire)
Feb-12-24 04:41PM	Oragenics, Inc. Announces Leadership Transition (Business Wire) -5.54% -11.47%
Feb-07-24 08:00AM	Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement (Business Wire) +24.08%
Feb-05-24 08:00AM	Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion (Business Wire) -6.06%
Jan-23-24 05:34PM	Oragenics Announces Termination of At-The-Market Offering Program (Business Wire)
Jan-02-24 07:30AM	Oragenics Completes Acquisition of Odyssey Healths Neurological Assets (Business Wire) +20.51%
Nov-10-23 09:19AM	Oragenics: Q3 Earnings Snapshot (Associated Press Finance)
Nov-02-23 07:00AM	Oragenics Issues Update to Shareholders (Business Wire)
Oct-18-23 08:30AM	Oragenics Announces Appointment of Bruce Cassidy and John Gandolfo to Board of Directors (Business Wire)
08:30AM	Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. (ACCESSWIRE)
Oct-05-23 06:30AM	Oragenics to Acquire Odyssey Healths Neurological Drug Technology Pipeline Including Concussion Drug Candidate (Business Wire) +13.00%
Sep-29-23 04:00PM	Oragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets (Business Wire)
Aug-14-23 02:46PM	Oragenics: Q2 Earnings Snapshot (Associated Press Finance)
Aug-07-23 08:30AM	Oragenics, Inc. Announces Private Placement (Business Wire)
Jun-05-23 04:18PM	Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM (Business Wire)
May-12-23 06:32PM	Oragenics: Q1 Earnings Snapshot (AP Finance)
Mar-29-23 11:45AM	Oragenics to Participate in the World Vaccine Congress Washington (Business Wire)
Mar-14-23 08:30AM	Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE (Business Wire)
Mar-08-23 09:09AM	Oragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team (Business Wire)
Mar-01-23 01:47PM	Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact (Benzinga)
07:30AM	Oragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidate (Business Wire)
Feb-03-23 07:30AM	Oragenics, Inc. Regains Compliance with NYSE American (Business Wire) +5.12%
Jan-30-23 02:24PM	7 Short-Squeeze Stocks to Buy Before They Soar (InvestorPlace) +7.58%
Dec-23-22 04:05PM	Oragenics, Inc. Discloses One-for-Sixty Reverse Stock Split (Business Wire) -6.69% -13.72%
Dec-22-22 07:30AM	Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate (Business Wire) +17.73%
Dec-20-22 04:36PM	Oragenics, Inc. Receives NYSE American Notice (Business Wire) -19.22%
Dec-19-22 04:34PM	Oragenics, Inc. Announces New Chair (Business Wire)
Oct-24-22 04:01PM	Oragenics to Participate in the 2022 BioFlorida Annual Conference (Business Wire)
Sep-30-22 07:30AM	Oragenics Issues Letter to Shareholders (Business Wire)
Aug-24-22 07:00AM	Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate (Business Wire) -5.48%
Jun-23-22 04:30PM	Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer (Business Wire) +8.47%
Jun-14-22 07:30AM	Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports (Business Wire)
May-17-22 07:30AM	Oragenics Issues Letter to Shareholders (Business Wire)

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Sarasota, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Telling Fred	Director	Dec 12 '25	Sale	0.94	210	198	34,538	Dec 15 04:38 PM
Frederick W. Telling	Director	Dec 12 '25	Proposed Sale	0.91	210	192		Dec 12 06:28 PM
Odyssey Health, Inc.	10% Owner	Jun 18 '25	Sale	4.26	5,044	21,487	0	Jun 18 05:10 PM
Odyssey Health, Inc.	10% Owner	Jun 17 '25	Sale	4.46	2,000	8,920	5,044	Jun 18 05:10 PM
Odyssey Health, Inc.	10% Owner	Jun 16 '25	Sale	4.45	5,000	22,250	7,044	Jun 16 06:01 PM
Odyssey Health, Inc.	10% Owner	Jun 13 '25	Sale	4.27	5,000	21,350	12,044	Jun 16 06:01 PM
Odyssey Health, Inc.	Stockholder	Jun 10 '25	Proposed Sale	4.69	17,044	79,936		Jun 13 03:09 PM

ECAT

BlackRock ESG Capital Allocation Term Trust

PGR

Progressive Corp

GWRE

Guidewire Software Inc

OGEN

Oragenics Inc

Upgrade your FINVIZ experience